Scientific article
English

Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy

Published inOptometry and Vision Science, vol. 96, no. 7, p. 500-506
Publication date2019
Abstract

Central serous chorioretinopathy (CSCR) is still a therapeutic challenge with no criterion standard treatment. However, anatomic changes at the level of the retinal pigment epithelium could prove of predictive value in the course of the disease for selective treatment in cases of increased risk of chronicity.

Citation (ISO format)
WUARIN, Raphaël et al. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy. In: Optometry and Vision Science, 2019, vol. 96, n° 7, p. 500–506. doi: 10.1097/OPX.0000000000001394
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1040-5488
408views
0downloads

Technical informations

Creation30/10/2019 19:25:00
First validation30/10/2019 19:25:00
Update15/03/2023 21:16:46
Status update15/03/2023 21:16:45
Last indexation31/10/2024 18:02:46
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack